A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

Clinical trial NCT01606566 · TERMINATED

Trial details

NCT number: NCT01606566
Sponsor: PCI Biotech AS
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Head and Neck Cancer Carcinoma, Squamous Cell of Head and Neck

Start date: 2012-04-01
Primary completion: 2015-08-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.